🇺🇸 FDA
Patent

US 8829022

N-substituted indenoisoquinolines and syntheses thereof

granted A61KA61K31/473A61K31/4741

Quick answer

US patent 8829022 (N-substituted indenoisoquinolines and syntheses thereof) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/473, A61K31/4741, A61P, A61P35/00